Sanofi Pasteur
Sanofi is dedicated to advancing immunoscience and developing innovative vaccines to protect global health across various infectious diseases. With a focus on research, manufacturing, and supply, Sanofi aims to create a healthier future by preventing diseases such as influenza, meningococcal meningitis, yellow fever, rabies, and more. The company is committed to global health initiatives, including the WHO's strategies to defeat meningitis and eliminate yellow fever epidemics, and actively supports vaccination programs worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence
US-12320753-B2
View Details
Methods for determining adjuvanted protein concentration and percent adsorption using intrinsic fluorescence
US-12320753-B2
View DetailsProducts
Influenza vaccines (seasonal and next-generation)
Vaccines developed using multiple platforms (including mRNA and protein-based approaches) and antigen-selection methods to prevent influenza and reduce complications.
Yellow fever vaccine
Vaccine intended to provide protection against yellow fever; referenced as a single-dose option for long-term protection and supplied to international stockpiles for epidemic response.
Dengue vaccine
Vaccine registered in multiple endemic countries to help manage and control dengue infections and reduce severe disease.
Hepatitis A vaccines (adult and pediatric)
Separate vaccine formulations for adults and children to prevent hepatitis A infection.
Hepatitis B vaccine (including combination administration)
Vaccine to prevent hepatitis B, commonly administered alone or as part of multivalent childhood vaccine combinations (pentavalent/hexavalent).
Rabies vaccine
Vaccine used for pre-exposure and post-exposure immunization against rabies; part of long-term rabies vaccine manufacturing and supply activities.
Influenza vaccines (seasonal and next-generation)
Vaccines developed using multiple platforms (including mRNA and protein-based approaches) and antigen-selection methods to prevent influenza and reduce complications.
Yellow fever vaccine
Vaccine intended to provide protection against yellow fever; referenced as a single-dose option for long-term protection and supplied to international stockpiles for epidemic response.
Dengue vaccine
Vaccine registered in multiple endemic countries to help manage and control dengue infections and reduce severe disease.
Hepatitis A vaccines (adult and pediatric)
Separate vaccine formulations for adults and children to prevent hepatitis A infection.
Hepatitis B vaccine (including combination administration)
Vaccine to prevent hepatitis B, commonly administered alone or as part of multivalent childhood vaccine combinations (pentavalent/hexavalent).
Rabies vaccine
Vaccine used for pre-exposure and post-exposure immunization against rabies; part of long-term rabies vaccine manufacturing and supply activities.
Services
High-volume production and distribution of preventive vaccines to national programs, global stockpiles and partners.
Planning and supply support for preventive mass vaccination campaigns and contributions to international stockpiles for epidemic response.
Collaborative initiatives with foundations, patient groups and international organizations to raise disease awareness and improve vaccine uptake.
High-volume production and distribution of preventive vaccines to national programs, global stockpiles and partners.
Planning and supply support for preventive mass vaccination campaigns and contributions to international stockpiles for epidemic response.
Collaborative initiatives with foundations, patient groups and international organizations to raise disease awareness and improve vaccine uptake.
Expertise Areas
- Vaccine research and immunoscience
- Next-generation vaccine platform development
- Combination vaccine formulation and pediatric immunization
- Large-scale vaccine manufacturing and supply chain
Key Technologies
- mRNA vaccine platforms
- Protein-based vaccine platforms
- Antigen selection methods
- Combination (multivalent) vaccine formulations